Free sample for Acetyl L Carnitine Max Dosage - Other Protected Amino Acids for Disulfide bond – Gentolex
Free sample for Acetyl L Carnitine Max Dosage - Other Protected Amino Acids for Disulfide bond – Gentolex Detail:
Product Detail
|
NO |
Products |
CAS No |
Application |
Key Quality Indicator |
||||
|
Purity |
Isomer |
Specific impurity |
*Max1 |
Moisture |
||||
|
1 |
Fmoc-Cys(Acm)-OH |
86060-81-3 |
Disulfide bond |
≥99.0% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
2 |
Fmoc-Cys(Mmt)-OH |
177582-21-7 |
Disulfide bond |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
3 |
Fmoc-Cys(4-allylbutyrate)-OH |
/ |
Disulfide bond |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
4 |
Mpa(Trt)-OH |
27144-18-9 |
End of sequence |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
5 |
Fmoc-Thr(tBu)-OL |
189337-28-8 |
Octreotide |
≥97.0% |
≤0.3% |
≤0.5% |
≤1.0% |
≤1.0% |
|
6 |
Fmoc-D-Arg(pbf)-OH |
187618-60-6 |
Desmopressin |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤2.0% |
|
7 |
Fmoc-Gly-Gly-OH |
35665-38-4 |
Bivalirudin |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
8 |
Fmoc-Gly-Gly-Gly-OH |
170941-79-4 |
Terlipressin |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
9 |
Fmoc-Gly-Gly-Gly-Gly-OH |
/ |
Bivalirudin |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
10 |
Fmoc-Gly-Asp(tBu)-OH |
/ |
Bivalirudin |
≥99.5% |
/ |
≤0.15% |
≤0.2% |
≤1.0% |
|
11 |
Boc-Cys(Trt)-OH |
21947-98-8 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
12 |
Boc-Arg(pbf)-OH |
200124-22-7 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
13 |
Boc-Ala-OH |
15761-38-3 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
14 |
Boc-D-Phe-OH |
18942-49-9 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
15 |
Boc-Gly-OH |
4530-20-5 |
End of sequence |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
16 |
Boc-Lys(Boc)-OH.DCHA |
15098-69-8 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
17 |
Boc-Ser(tBu)-OH |
7738-22-9 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
18 |
Boc-Thr(tBu)-OH |
13734-40-2 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
19 |
Boc-D-Ala-OH |
7764-95-6 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
20 |
Boc-Met-OH |
2488-15-5 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
21 |
Boc-Tyr(tBu)-OH |
47375-34-8 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
22 |
Boc-D-Arg(pdf)-OH |
187618-60-6 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
23 |
Boc-Asp(OtBu)-OH.DCHA |
1913/12/8 |
End of sequence |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
24 |
Fmoc-HomoArg(pbf)-OH |
1159680-21-3 |
Eptifibatide |
≥98.5% |
≤0.2% |
/ |
≤0.5% |
≤2.0% |
|
25 |
Fmoc-Asp-OtBu |
129460-09-9 |
Thymalfasin |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
26 |
Fmoc-Tyr(Me)-OH |
77128-72-4 |
Carbetocin |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
27 |
Fmoc-Orn(Boc)-OH |
109425-55-0 |
Atosiban Omnipressin Daptomycin |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤2.0% |
|
28 |
Fmoc-D-Tyr(Et)-OH |
162502-65-0 |
Atosiban |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
29 |
Fmoc-Asp(OAll)-OH |
146982-24-3 |
Melanotan |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
30 |
Ac-Nle-OH |
15891-49-3 |
Melanotan |
≥99.0% |
/ |
≤0.3% |
≤0.3% |
≤1.0% |
|
31 |
Fmoc-Nle-OH |
77284-32-3 |
Melanotan Afamelanotide |
≥99.0% |
/ |
≤0.3% |
≤0.3% |
≤1.0% |
|
32 |
Ac-Glu(OtBu)-OH |
84192-88-1 |
Argireline Acetyl octapeptide-3 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
33 |
Ac-β-Ala-OH·DCHA |
/ |
Acetyl tetrapeptide-5 |
≥99.0% |
/ |
≤0.3% |
≤0.3% |
≤1.0% |
|
34 |
Fmoc-ß-Ala-OH |
35737-10-1 |
Acetyl tetrapeptide-5 |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
35 |
Fmoc-Hyp(tBu)-OH |
122996-47-8 |
Icatibant |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
36 |
Fmoc-Thi-OH |
130309-35-2 |
Icatibant |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
37 |
Fmoc-D-Tic-OH |
130309-33-0 |
Icatibant |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
38 |
Fmoc-Oic-OH |
130309-37-4 |
Icatibant |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
39 |
Boc-Sar-OH |
13734-36-6 |
Saralasin |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
40 |
Fmoc-Sar-OH |
77128-70-2 |
Saralasin |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
41 |
Fmoc-Tyr(SO3Na)-OH.H2O |
106864-37-3 |
Sincalide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
42 |
Fmoc-D-Asp(OtBu)-OH |
112883-39-3 |
Daptomycin |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
43 |
Ac-Ser(tBu)-OH |
77285-09-7 |
Afamelanotide |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
44 |
Boc-HomoCys(Trt)-OH |
201419-16-1 |
Depreotide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
45 |
Fmoc-HomoCys(Trt)-OH |
167015-23-8 |
Depreotide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
46 |
Fmoc-Dab-OH |
161420-87-7 |
Snake venom |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
*Max1 = Max Unknown Purity
Other Indicator:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
- Max Unknow Impurity: Fmoc-Trp(Boc)-OH (143824-78-6) ≤0.3%; Others ≤0.2%
Product detail pictures:
Related Product Guide:
We can constantly satisfy our respected customers with our good high quality, good price tag and good support due to we have been additional specialist and extra hard-working and do it in cost-effective way for Free sample for Acetyl L Carnitine Max Dosage - Other Protected Amino Acids for Disulfide bond – Gentolex , The product will supply to all over the world, such as: Ethiopia, Australia, Malta, Insisting over the high-quality generation line management and prospects guide provider, we have made our resolution to offer our shoppers using the initially stage purchasing and soon after provider working experience. Preserving the prevailing helpful relations with our prospects, we even now innovate our product lists the many time to meet up with the brand new wants and stick to the latest trend of this business in Ahmedabad. We're ready to facial area the difficulties and make the transform to grasp many of the possibilities in international trade.
By John biddlestone from Georgia - 2018.12.30 10:21
The company keeps to the operation concept "scientific management, high quality and efficiency primacy, customer supreme", we have always maintained business cooperation. Work with you,we feel easy!
By Candance from United States - 2018.09.16 11:31
